C-terminally truncated surface proteins of hepatitis B virus (HBV) are frequently translated from genomically integrated viral sequences. They may be relevant for hepatocarcinogenesis by stimulating gene expression. First, we examined the transactivating potential of middle hepatitis B surface protein truncated at amino acid (aa) position 167 (MHBs t167 ) on the HBV regulatory element. In transient cotransfection assays using Chang liver or HepG2 cell lines and chloramphenicol acetyltransferase (CAT) reporter constructs only the HBV enhancer I, but no other HBV regulatory elements like the X promoter, the S1 or S2 promoter or the enhancer II/core promoter could be stimulated by MHBs t167 . Since there is no evidence for a direct
Introduction
Hepatitis B virus (HBV), a member of the hepadnavirus family, has a partially double-stranded 3n2 kb DNA genome which contains four open reading frames (ORFs) encoding the surface, core, polymerase and HBx protein. The transcription of these genes is under the control of four promoters, two for the surface (S) gene (Raney et al., 1991 ; Yuh et al., 1992) , one for the core (C) gene and the polymerase (Pol) gene (Yuh et al., 1992) and one for the X gene (Siddiqui et al., 1987) . In addition, interaction of MHBs t167 with DNA, we subsequently analysed whether cellular transcription factors were involved in mediating transactivation. This was tested both with isolated transcription-factor-binding sites and in the natural context of viral and cellular promoter elements. Deletion analysis and electrophoretic mobility shift assays revealed that Sp1, AP1 and NF-κB can mediate transactivation by MHBs t167 . No involvement of CREB, NF1 or the liverspecific factor C/EBP was found. These data indicate that MHBs t167 is a pleiotropic, non-liver-specific transactivator which exerts its effect via ubiquitous cellular transcription factors that are also involved in the regulation of expression of cellular genes relevant for proliferation and inflammation.
two enhancer elements regulate HBV gene expression. Enhancer I is located upstream of the X gene and overlaps the X promoter (Shaul et al., 1985 ; Zhang et al., 1992) . Enhancer II is located within the X ORF and is associated with the C promoter (Yee, 1989) .
Worldwide, HBV is an important cause of both acute and chronic liver disease. Chronic HBV carriers have an increased risk of developing hepatocellular carcinoma (HCC). The basis for carcinogenesis by HBV is poorly understood. A possible mechanism of hepatocarcinogenesis could be activation by viral proteins of the expression of cellular genes involved in cell growth regulation. The HBx protein of HBV was shown to act as such a transcriptional transactivator, stimulating various viral and cellular enhancer and promoter elements (for review see Caselmann, 1996) .
Transactivating functions have also been attributed to viral proteins translated from 3h-truncated HBV preS\S sequences that are frequently found to persist in human HCCs Kekule! et al., 1990) . The wild-type middle hepatitis B virus surface protein (MHBs) consists of a 55 aa preS2-domain and a 226 aa S-domain (Machida et al., 1983) . To generate the transactivating forms of MHBs, deletion of at least 87 C-terminal aa is required (Natoli et al., 1992 ; Lauer et al., 1992) . Truncation up to aa 76 results in a retention of MHBs t in the endoplasmic reticulum (ER), whereas deletion of the complete S-region and two C-terminal aa of the preS2-domain leads to a cytoplasmic localization of the MHBs t transactivator (Meyer et al., 1992 ; Hildt et al., 1993 Hildt et al., , 1995 Schlu$ ter et al., 1994) . Deletion and mutation analyses resulting in truncated and modified MHBs proteins revealed that the region between aa 41 and 52 of the preS2-region containing an amphipathic α-helix mediates dimerization of the transactivator proteins. There is evidence that dimerization is a prerequisite for the functionality of the MHBs t activator (Hildt et al., 1995) .
MHBs t molecules seem to act as a pleiotropic activator of various promoter and enhancer elements without binding to DNA directly. Besides activation of viral elements like the simian virus 40 (SV40) early enhancer , the LTRs of Rous sarcoma virus (RSV), human immunodeficiency virus-1 (HIV-1) and human T cell lymphotropic virus type I (HTLV-I ; Meyer et al., 1992 ; Lauer et al., 1994) , stimulation of the promoter sequences of the oncogenes c-myc Natoli et al., 1992 ; Lauer et al., 1994) , c-fos (Meyer et al., 1992 , Natoli et al., 1992 Lauer et al., 1994 ; Schlu$ ter et al., 1994) and the interleukin-6 gene (Meyer et al., 1992) has been shown. Furthermore, MHBs t mediates its transactivating effect via factors binding to the serumresponsive element (SRE), to 12-O-tetradecanoylphorbol 13-acetate-responsive elements (TREs ; Natoli et al., 1992) , NF-κB- (Meyer et al., 1992 ; Natoli et al., 1992 ; Lauer et al., 1994 ; Mu$ hlbauer & Koch, 1995) , AP1- (Hildt et al., 1993 ; Lauer et al., 1994 ; Mu$ hlbauer & Koch, 1995) and AP2- (Lauer et al., 1994) binding sites.
In this study, we first analysed the transactivating potential of MHBs t"'( on HBV cis-acting elements and subsequently identified cellular transcription factors involved in the mediation of transactivation.
Methods
Cell culture. Chang liver cells (ATCC CCL13) and HepG2 cells (ATCC HB8065) were cultivated at 37 mC, 5 % CO # and 90 % relative humidity in Dulbecco's modified Eagle's medium (DMEM, Gibco BRL) supplemented with 10 % foetal calf serum and 100 µg\ml kanamycin.
Construction of plasmids.
The construction of the HBV expression vector pCMVS486s containing HBV preS\S nucleotides 3163-486 and the corresponding antisense plasmid pCMVS486a using the cloning vector pRc\CMVstop has been described previously (Meyer et al., 1992) .
The HBV promoter\enhancer sequences were derived from plasmid pHBVdi harbouring a dimer of the HBV adw genome (kindly provided by H. Will) and were subcloned in the SmaI site of the promoter insertion vector pGCAT-C (Frebourg & Brison, 1988) . Plasmid pSP1cat containing the chloramphenicol acetyltransferase (CAT) gene under the control of the HBV S gene promoter 1 was generated by insertion of a HincII-BstEII (nt 2589-2821) fragment of pHBVdi that had been blunt-ended with Klenow polymerase. The insertion into plasmid pGCAT-C of a HaeIII fragment (nt 3024-3187), covering the S promoter 2, generated pSP2cat. Similarly, the insertion of a HincII-RsaI (nt 1684-1849) encompassing the enhancer II\C promoter sequences gave rise to pEPCcat. The X promoter and enhancer-X promoter driven constructs, pPX and pEPX, were obtained by insertion of a blunt-ended SphI-NcoI (nt 1236-1372) and a blunt-ended DraI-NcoI (nt 833-1372) fragment of pHBVdi, respectively.
The CAT reporter plasmid pTK-105\j51cat controlled by the herpes simplex virus (HSV) thymidine kinase (TK) promoter and the deletion constructs pTK-95\j51cat, pTK-70\j51cat and pTK-37\ j51cat (McKnight & Kingsbury, 1982 ; see Figs 2 and 4) were used as described elsewhere. To generate plasmids p2xNF1-37TKcat and p2xSp1-37TKcat (see Fig. 4 ), constructs pG29NFTKcat and pG29SpTKcat (Schule et al., 1988) were cut with NaeI and NheI to remove the glucocorticoid-responsive element. The cohesive ends were blunted with Klenow polymerase and religated. In the resulting intermediate constructs the full-length TK promoter (k105\j51) was replaced by a XhoI-BamHI fragment carrying the TK minimal promoter (k37\j51).
Double-stranded oligonucleotides containing either a consensus stimulatory protein 1 (Sp1)-binding site (5h GGGCGGG 3h) or a mutated Sp1 motif (5h GGGGGGG 3h) fused to SalI-linkers were cloned in the SalI site of pTK-37\j51cat to generate plasmids pSp1 ha -37TKcat and pSp1 mut -37TKcat, respectively (see Fig. 4 ). Similarly, plasmids pCRE37TKcat and pC\EBP-37TKcat were constructed by fusing monomeric binding sites for the transcription factors CREB (5h TGACGTCA 3h) and C\EBP (5h GTTGCGCAAC 3h) to the TK minimal promoter in pTK37\j51cat (see Fig. 2 ). Plasmids p2xκB-37TKcat and p3xAP1-37TKcat were obtained by the insertion of two NF-κB motifs (5h GGGACTTTCC 3h) and three AP1 motifs (5h TGACTCA 3h) flanked by HindIII-XbaI sites, respectively, in the HindIII-XbaI site of pTK-37\j51cat (see Fig. 2 ).
Plasmid pRascat containing 420 bp of the human c-Ha-ras-1 promoter with six Sp1 binding sites fused to the CAT gene (Ishii et al., 1986) was kindly provided by I. Pastan (NIH, Bethesda, Md., USA).
All plasmids were sequenced to check for structural integrity. Transfections and reporter gene assays. Chang liver cells or HepG2 cells were seeded out the day prior to transfection at a density of 4n5i10& or 6i10& cells per 60 mm dish, respectively. Reporter plasmid (0n2-5 µg) was cotransfected with 0n25-0n50 µg of activator plasmid by the calcium phosphate method. For the detection of CAT activity, cells were harvested 38-44 h post-transfection with PBS-10 mM EDTA, resuspended in 200 µl 250 mM Tris-HCl, pH 7n8, 5 mM EDTA and lysed by four cycles of freeze-thawing. Total cellular protein was quantified using a protein determination kit (Bio-Rad). Equal amounts of protein were assayed for CAT activity as described previously (Meyer et al., 1992) . Transfections and CAT assays were performed at least three times in triplicates.
Electrophoretic mobility shift assay. HepG2 cells (1n5i10') were seeded onto tissue culture dishes and transfected 24 h later with 5 µg of plasmids pRc\CMV or pCMVS486s, respectively. For chemical stimulation, seeded cells were treated with 100 ng\ml phorbol 12-myristate 13-acetate (PMA) for 90 min prior to harvesting. Nuclear extracts were prepared 62 h after transfection as described by Dignam et al. (1983) . Binding reactions were performed with 3-5 µg protein in 10 mM Tris-HCl, pH 7n5, 50 mM NaCl, 1 mM EDTA, 10 % glycerol, 1-1n5 µg acetylated BSA, 2 µg poly(dI*C), 0n1 mM DTT and 0n1 mM Pleiotropic transactivation by HBV Pleiotropic transactivation by HBV PMSF and 40 000 c.p.m. of α-$#P-labelled oligonucleotide in a final volume of 20 µl for 25 min on ice. In experiments to detect binding activities of AP1, 5 mM MgCl # was included. DNA-protein complexes were electrophoresed on native 4n5 % polyacrylamide gels at 25 mA in 34 mM Tris-HCl, pH 7n5, 17 mM sodium acetate, 0n5 mM EDTA, pH 8n0. Gels were vacuum-dried and exposed to Amersham MP films at k80 mC.
The sequences of the oligonucleotides used are depicted below. The transcription factor binding motifs are underlined :
5h AGTTGAGGGGACTTTCCCAGGC 3h 3h TCAACTCCCCTGAAAGGGTCCG 5h AP1 :
5h TTCCGGCTGACTCATCAAGCG 3h 3h AAGGCCGACTGAGTAGTTCGC 5h
Results

MHBs t167 stimulates gene expression from HBV enhancer I
Previous studies have shown transactivation of different cellular and viral target sequences by C-terminally truncated MHBs proteins Kekule! et al., 1990 ; Meyer et al., 1992 ; Natoli et al., 1992 ; Hildt et al., 1993 ; Lauer et al., 1994 ; Schlu$ ter et al., 1994) . However, none of them has examined the MHBs t -dependent stimulation of endogenous HBV-regulatory sequences. Therefore, in order to investigate whether gene expression directed by HBV regulatory elements is also influenced by MHBs t production, we performed transient cotransfection assays on both Chang liver and HepG2 cells using a reporter plasmid and an activator plasmid. We constructed reporter plasmids expressing the CAT gene under control of the HBV surface antigen promoters 1 or 2 (pSP1cat and pSP2cat, respectively), the X gene promoter (pPXcat), the enhancer I and the X gene promoter (pEPXcat) or the enhancer II\core gene promoter (pEPCcat) (see Fig. 1 ). The activator plasmid pCMVS486s contains the HBV preS2\S gene truncated at nt 486 under the control of the cytomegalovirus enhancer\promotor. The cloning vector pRc\CMVstop containing no HBV sequences was used in separate cotransfections to determine the level of background expression from the different reporter constructs. Basic expression and transactivation was determined indirectly using a CAT activity assay as described in Methods.
CAT expression experiments with extracts of HepG2 cells cotransfected with the reporter plasmids and the activator plasmid pCMVS486s (S t in Fig. 1 ) revealed that CAT gene expression was stimulated 18-fold exclusively from the HBV enhancer I\X gene promoter construct pEPXcat (Fig. 1, on the HSV TK minimal promoter (pTK-37/j51cat), and on AP1-dependent (p3xAP1-37TKcat), NF-κB-dependent (p2xkB-37TKcat), C/EBP-dependent (pC/EBP-37TKcat) and CREB-dependent (pCRE-37TKcat) reporter constructs. HepG2 cells were cotransfected with 2 µg of the indicated CAT construct and 0n4 µg of the activator plasmid pCMVS484s or the cloning vector pRc/CMVstop, respectively. As shown in the bottom lines, 1n5 µg of plasmid pMSVC/EBP overexpressing C/EBP or of plasmid pSKG4PKA encoding the PKA catalytic subunit which phosphorylates and activates CREB, was cotransfected as a control.
contains binding sites for liver-specific transcription factors such as C\EBP as well as for ubiquitous transcription factors like AP1, CREB, NF1 and a NF-κB-like motif (Trujillo et al., 1991 ; Gustin et al., 1993) . To determine the factors mediating the transactivating effect, we tested which of the corresponding factor-binding sites are essential for transactivation by MHBs t"'( . Consensus binding sites for the transcription factors AP1, CREB, C\EBP and NF-κB were fused to a non-inducible HSV TK minimal promoter (pTK-37\j51cat), resulting in plasmids p3xAP1-37TKcat, pCRE-37TKcat, pC\EBP-37TKcat and p2xκB-37TKcat (Fig. 2) . In cotransfection experiments with HepG2 cells the AP1-and NF-κB-controlled CAT gene expression was stimulated about 8-and 27-fold, respectively, whereas no effect of MHBs t"'( was detected using CREBor C\EBP-dependent reporter constructs (Fig. 2) . The functionality of the latter two reporter gene constructs was verified as follows : the inducibility of indicator gene expression of pCRE-37TKcat was shown by coexpression of the catalytic subunit of protein kinase A (PKA) from plasmid pSKG4PKA (Fig. 2) , which is known to phosphorylate and thereby to activate CREB (Gonzalez & Montminy, 1989) . In the case of pC\EBP-37TKcat, stimulation of reporter gene expression was achieved by overexpression of C\EBP cDNA from plasmid pMSVC\EBP (Karin, 1991 ;  Fig. 2 ), since HepG2 cells are known to contain only approximately 10 % of the C\EBP concentrations of normal liver tissue. As expected, the C\EBP expression led to a dramatic increase of baseline indicator gene expression from the C\EBP-controlled reporter plasmid pC\ EBP-37TKcat. However, no further stimulation was observed when MHBs t"'( and C\EBP were coexpressed in HepG2 cells (Fig. 2) . The above data strongly indicate that MHBs t"'( is able to activate AP1-and NF-κB-dependent gene expression, but not C\EBP-or CREB-mediated stimulation.
To confirm our results in an independent test-system we investigated whether the expression of MHBs t"'( increases DNA-binding activity of AP1 and NF-κB in electrophoretic BEJA Pleiotropic transactivation by HBV Pleiotropic transactivation by HBV Fig. 4 . Effect of MHBs t167 on the activity of the HSV TK promotor and on SP1-and NF1-dependent gene expression. CCL13 cells were transfected with 3 µg of the indicated CAT reporter constructs and 0n4 µg of the expression plasmids pRc/CMVstop (vector control), the sense expression construct pCMVS486s or the antisense construct pCMVS486a. The activation factor is given as compared with the vector control. The drawings on the left reflect the various 5h-deletion constructs of the HSV TK promoter and the constructs comprising isolated wildtype or mutated transcription-factorbinding sites as described in Methods. mobility shift assays. In nuclear extracts prepared from HepG2 cells transfected with the vector pRc\CMVstop a low basal level of constitutive NF-κB (data not shown) and AP1 DNAbinding activity (Fig. 3, lane 4) , was found. MHBs t"'( significantly increased the ability of both factors to bind to $#P-labelled DNA oligonucleotides containing either an AP1 (Fig.  3, lane 2) or an NF-κB motif (data not shown). The specificity of the complexes induced by the expression of MHBs t"'( was demonstrated by competition experiments using a 100-fold molar excess of unlabelled DNA (jComp ; Fig. 3, lane 1) . Furthermore, the complexes induced by MHBs t"'( were indistinguishable from complexes formed after treatment with PMA of cells (Fig. 3, lane 3) that have previously been shown to contain NF-κB (Angel et al., 1987) or AP1 (Mauxion et al., 1991) , respectively. These data provide additional evidence that transactivation by MHBs t"'( relies on the recruitment of ubiquitous cellular transcription factors like AP1 and NF-κB and indicate that transactivation by MHBs t"'( does not seem to be restricted to a particular cell type.
MHBs t167 activates gene expression from the HSV TK promoter via an Sp1 motif
Our findings that MHBs t"'( activates gene expression via the common cellular transcription factors AP1 and NF-κB prompted us to investigate whether other ubiquitous transcription factors are targets of MHBs t"'( function. Therefore, we selected the well-characterized HSV TK promotor, which is lacking both AP1 and NF-κB motifs (see Fig. 4 , top line). Cotransfections of CCL13 cells were performed with 7n5 µg of activator plasmid pCMVS486s and 3 µg of indicator plasmid pTK-105\j51cat, which contains the CAT gene under the control of the HSV TK promoter (Jones & Tjian, 1985) . This promoter (nt k105 to j51) contains two Sp1-binding sites of different binding affinities, as well as a single CAAT motif to which factors of the NF1 and C\EBP families bind ( Fig. 4 ; Kadonaga et al., 1986) . A 10-fold stimulation of CAT gene expression was observed in this system. To investigate which transcription factors are involved in transactivation by MHBs t"'( directed from the HSV TK promoter, we used plasmids with different 5h-terminal deletions in the TK promoter region, resulting in a stepwise removal of different factor-binding sites. Stimulation of CAT gene expression of these deletion plasmids was evaluated in cotransfection experiments with the activator plasmid pCMVS486s. In these experiments, the antisense construct pCMVS486a containing the preS2\S transactivator sequences in inverted orientation and the cloning vector pRc\CMVstop served as negative controls. From the complete HSV TK promoter in plasmid pTK-105\51cat CAT gene expression was stimulated about 10-fold (Fig. 4) by MHBs t"'( . In construct pTK-95\j51cat containing the CAAT box and the proximal low bindingaffinity Sp1 site, the distal high-affinity Sp1-binding site has been deleted. Transient expression of MHBs t"'( resulted in no significant (1n2-fold) activation of the reporter gene expression (Fig. 4) . Further deletion of the NF1 site (pTK-70\j51cat) as well as an additional deletion of the proximal low bindingaffinity Sp1 site (pTK-37\j51cat ; TATA minimal promoter construct) did not alter this result (Fig. 4) . Therefore, we conclude that the presence of the CAAT box and the proximal low-affinity Sp1 site are not sufficient to render the minimal HSV TK promoter responsive to stimulation by the MHBs t"'( transactivator. The proximal Sp1 site of HSV TK (5h GGGGCGGCG 3h) does not match well with the Sp1 consensus sequence and thus binds Sp1 only with low affinity (Jones & Tjian, 1985) . Furthermore, it acts as a semiindependent promoter element that has only a modest effect on the overall activity of the HSV TK promoter (Jones & Tjian, 1985) . By contrast, the distal Sp1 site (5h GGGGCGGGT 3h) binds the factor with high affinity and is essential for HSV TK promoter activity. To further delineate the involvement of the Sp1 transcription factor in activation by MHBs t"'( , we constructed various plasmids containing the minimal TK promoter (nt -37 to j51) fused to different isolated factor-binding sites controlling CAT gene expression. Cotransfection of CCL13 cells with plasmid pCMVS486s and the HSV TK reporter construct p2xSp1-37TKcat, which contains the low-Sp1-binding-affinity GC-boxes III and IV of the SV40 early promoter (Fig. 4) , resulted in a 6n7-fold stimulation of CAT gene expression. Reporter gene expression from an analogous construct (p2xNF1-37TKcat, containing two NF1 consensus sequences) was not inducible by MHBs t"'( (Fig. 4) . In addition, we linked a single high-affinity Sp1-binding site (5h GGGGCGGGG 3h ; pSp1 ha -37TKcat) or a mutated Sp1 motif (5h GGGGGGGGG 3h ; pSp1 mut -37TKcat) to the HSV TK minimal promoter. CAT gene expression was stimulated about 23-fold by the presence of the high-affinity Sp1-binding site, whereas the mutated pSp1 mut -37TKcat construct showed only weak inducibility by MHBs t"'( (Fig. 4) . These results demonstrate that Sp1, but not NF1 binding motifs, render the HSV TK promoter responsive to transactivation by MHBs t"'( . Both the structural integrity as well as the binding affinity of the Sp1 motif are important factors for the intensity of the stimulatory effect of MHBs t"'( . Finally, we determined the importance of Sp1 for transactivation of gene expression from cellular regulatory elements like the c-Ha-ras promoter, which contains six Sp1-binding sites (Ishii et al., 1986) . Sp1-binding site III is located within a 47 bp element essential for up-regulation of c-Ha-ras gene expression (Lowndes et al., 1989) . In plasmid pRascat1 420 bp of c-Ha-ras 5h-regulatory sequences, 40 bp derived from the first exon and 30 bp of the first intron, are fused to the CAT gene (Fig. 5 a ; Ishii et al., 1986) . After cotransfection of CCL13 cells with plasmids pCMVS486s and pRascat1, CAT gene expression was increased about 7-fold with respect to the vector (pRc\CMVstop) and antisense (pCMVS486a) controls (Fig. 5 b) . This experiment suggests that MHBs t"'( does not only mediate transactivation via Sp1 from viral or synthetic minimal promoter constructs, as shown previously, but can stimulate Sp1-dependent expression of cellular genes also, which may have implications in deregulation of cellular growth and malignant hepatocyte transformation.
Discussion
The MHBs t"'( transactivator can stimulate gene expression from the endogenous HBV enhancer I. The activation appears to rely on a binding site for the ubiquitous cellular transcription factor AP1 or an NF-κB-like binding sequence, both of which are present on enhancer I, although an influence of other factors like C\EBP, NF1 or CREB cannot absolutely be ruled out in the context of the intact enhancer. This is, however, unlikely, since isolated binding sites for these factors are not susceptible to transactivation by MHBs t"'( . Activation of gene expression from enhancer I by MHBs t"'( resembles HBxmediated transactivation, which stimulates gene expression from enhancer I via an X-responsive element (XRE) that overlaps the binding sites for AP1 and CREB (Faktor & Shaul, 1990) . However, there are two major differences between MHBs t"'( and the HBx transactivator. First, HBx has been reported to facilitate binding of CREB to enhancer I by a direct BEJC association with members of the CREB transcription factor family . By contrast, a direct interaction with these transcription factors does not seem likely for MHBs t"'( , because it has been localized to membranes of the ER. In addition, we were not able to show an involvement of CREB in transactivation by MHBs t"'( . Second, whereas HBx stimulates gene expression from all HBV cis-regulatory elements (Caselmann, 1996) , most of these elements are not targets for transactivation by MHBs t"'( . The transcription factor NF1 has been shown to be important for optimal activity of the S2 promoter (Shaul et al., 1986 ; Raney et al., 1991) , and the enhancer II\C promoter carries several binding sites for the liver-specific factor C\EBP (Lopez-Cabrera et al., 1991) . Therefore, our results showing that SP2-and enhancer II\core-regulated gene transcription cannot be stimulated by MHBs t"'( are supported by the observation that minimal promoter constructs under the control of NF1 or C\EBP motifs did not respond to MHBs t"'( expression.
The described restriction for enhancer I-dependent gene activation by MHBs t"'( had prompted us to investigate which of the transcription-factor-binding sites located on enhancer I could mediate the activating effect of MHBs t"'( . We were able to show that MHBs t"'( acts via the ubiquitous transcription factors AP1 and NF-κB, but not via the transcription factors NF1, C\EBP and CREB. In addition transcription factor Sp1, which does not bind enhancer I, also mediates the activating potential of MHBs t"'( . In this respect, MHBs t"'( has a spectrum of activity similar to that of HBx which was shown to act via AP1, AP2, NF-κB and C\EBP (Seto et al., 1990 ; Mahe et al., 1991) . In contrast to HBx or the E1A transactivator of adenovirus, MHBs t"'( does not seem to be localized in the nucleus (Meyer et al., 1992) , and therefore, most likely does not interact directly with these transcription factors. All MHBs t"'( -induced factors are activated on the post-translational level by phosphorylation and\or dephosphorylation events (for review see Karin & Smeal, 1992) . Our previous studies revealed that the induction of NF-κB by MHBs t"'( relies on a prooxidant state of the cell that is most likely generated by an increase in the intracellular levels of reactive oxygen intermediates (ROIs ; Meyer et al., 1992) . However oxidative stress, such as that produced for example by micromolar concentrations of H # O # , not only induces NF-κB (Schreck et al., 1991) , but is also involved in activation of the c-fos and c-jun mRNAs (Devary et al., 1991 ; Nose et al., 1991) , whose products constitute the transcription factor AP1. A possible link between oxidative stress and the activation of transcription factors is the discovery of redox-regulated kinases (Bauskin et al., 1991) and phosphatases (Keyse & Emslie, 1992) . Therefore, it remains to be shown whether MHBs t"'( can induce redox-regulated enzymes.
Very recently, we were able to find a positive correlation between the transactivating potential of the HBV transactivator HBx and an increased concentration of oxidized guanosine residues in genomic DNA. 8OHdGs are generated by ROIs and lead to G-C T-A transversions, possibly resulting in mutated proteins involved in cell cycle regulation and tumour development. Experiments examining whether MHBs t expression induces increased 8OHdG formation are in progress.
Recent findings suggest that the activation of NF-κB and AP1 by truncated HBs proteins depends on a direct interaction with protein kinase C (PKC ; Natoli et al., 1992 ; E. Hildt, personal communication) and a stimulation of the c-Raf-1\MAP kinase pathway (E. Hildt, personal communication). These results are supported by the findings that MHBs t molecules have an altered membrane topology, directing the preS2 domain, which is sufficient for the transactivating function, into the cytosolic compartment (Hildt et al., 1995) . In contrast, the preS2 region of full-length MHBs is orientated towards the lumen of the ER. The preS2 domain of the HBV large surface protein (LHBs) is, like the MHBs t preS2 domain, located on the cytosolic side of the ER ; therefore, LHBs can also act as a transcriptional activator of various promoter elements by stimulation of PKC (E. Hildt and others, personal communication). The above data confirm the model of MHBs ttriggered transcriptional activation by a direct stimulation of cytosolic signal cascades.
The activity of the Sp1 transcription factor, which binds to GC-rich motifs present in the promoter region of cellular house-keeping genes, is regulated at the post-translational level by O-and N-linked glycosylation and by a DNAdependent kinase (Jackson & Tjian, 1988) . A retention of MHBs t"'( in the ER as described by Meyer et al. (1992) may influence the glycosylation pattern of Sp1 and thereby alter the activity of Sp1. However, we have shown that only a subset of Sp1-dependent promoters can be activated by MHBs t"'( . This can at least partially be explained by different binding-affinities of the tested Sp1 motifs. During our studies it became evident that high-and medium-affinity Sp1 sites are susceptible to transactivation, while low-affinity sites cannot be stimulated significantly. These findings might be an explanation for the inability of MHBs t"'( to stimulate the hepatitis B viral S2 promoter and core promoter, which contain four and three Sp1 factor-binding sites, respectively Zhang et al., 1993) , since these binding sites are not identical to the Sp1 consensus sequence. Activation of Sp1 by MHBs t"'( might also be dependent on the distance from the promoter region or the presence of other factor-binding sites, rather than on the number of specific binding-sites. For example, the cellular c-Haras promoter, which harbours six Sp1 motifs, as well as the TK promoter, which harbours only two Sp1-binding sites (Fig. 4) , can be activated, while the c-raf-1 promoter, which contains four Sp1 motifs, cannot (our unpublished results).
In conclusion, similar to the situation for the HBV transactivator HBx, the activating potential of MHBs t"'( is mediated via various ubiquitous transcription factors. These are involved in the activation of proto-oncogenes or genes expressed during inflammation. It is plausible that a consti-tutive overexpression of proto-oncogenes may induce proliferation or maintain mitogenesis. This model would establish a valuable link between transactivation by integrated HBV sequences and the development of hepatocellular carcinoma.
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